aTYR PHARMA (ATYR) Invested Capital (2014 - 2020)

aTYR PHARMA (ATYR) has 7 years of Invested Capital data on file, last reported at $3.1 million in Q3 2020.

• Quarterly Invested Capital fell 60.98% year-over-year to $3.1 million in Q3 2020, while the trailing twelve-month figure through Jun 2021 was $3.1 million (down 89.23% YoY) and the FY2019 annual result came in at $8.7 million, up 12.49% from the prior year.
• Invested Capital fell to $3.1 million in Q3 2020, from $5.0 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $8.7 million in Q4 2019 to a low of $339000.0 in Q4 2016.
• A 5-year average of $5.2 million and a median of $5.0 million in 2017 frame the typical range for Invested Capital.
• Annual changes were most pronounced in 2016 — Invested Capital plunged 89.93% — and 2017, when it jumped 1378.47%.
• Tracing ATYR's Invested Capital over 5 years: stood at $339000.0 in 2016, then jumped by 1378.47% to $5.0 million in 2017, then soared by 54.97% to $7.8 million in 2018, then gained by 12.49% to $8.7 million in 2019, then tumbled by 64.97% to $3.1 million in 2020.
• The last three Invested Capital figures came in at $3.1 million (Q3 2020), $5.0 million (Q2 2020), and $6.9 million (Q1 2020), per Business Quant data.